How Fasting Affects Metabolism: Hormones, Fat Burning, and Health Effects

This article is for informational purposes only. Consult a qualified healthcare professional for medical advice, diagnosis, or treatment.

What Happens When You Stop Eating?

Fasting—the voluntary abstention from food for defined periods—triggers a systematic sequence of metabolic adaptations as the body shifts from using dietary glucose to mobilizing stored energy. These adaptations involve changes in hormone levels, substrate utilization, cellular recycling processes, and gene expression. Understanding the physiology of fasting helps contextualize the evidence for various fasting protocols, from the widely practiced 16:8 intermittent fasting to extended multi-day fasts.

Phase 1: The Fed-to-Fasted Transition (0–6 Hours)

After a meal, blood glucose rises and the pancreas secretes insulin, which facilitates glucose uptake by cells and promotes glycogen storage in the liver (up to ~100 g) and muscles (up to ~400 g). Insulin also suppresses lipolysis—the breakdown of stored fat. As the meal is absorbed and blood glucose declines over 4–6 hours, insulin levels fall, glucagon rises, and the liver begins converting glycogen back to glucose (glycogenolysis) to maintain blood glucose between 70–100 mg/dL.

Phase 2: Glycogen Depletion and Fat Mobilization (6–24 Hours)

As glycogen stores are depleted—typically within 12–24 hours depending on prior diet and activity level—the body increasingly relies on fatty acid oxidation for energy. Adipose tissue releases free fatty acids (FFAs) and glycerol through lipolysis, driven by elevated glucagon and catecholamines and suppressed insulin. FFAs enter cells and are oxidized in the mitochondria via beta-oxidation. Glycerol undergoes gluconeogenesis in the liver to maintain blood glucose for obligate glucose consumers, including the red blood cells and parts of the kidney. Amino acids from muscle protein are also converted to glucose via gluconeogenesis, though protein catabolism is minimized through metabolic adaptations that prioritize fat.

Key Hormonal Changes During Fasting

Phase 3: Ketogenesis (24–72 Hours)

When glucose is scarce, the liver converts acetyl-CoA derived from fatty acid beta-oxidation into ketone bodies—primarily beta-hydroxybutyrate (BHB), acetoacetate, and acetone. Ketones are water-soluble, cross the blood-brain barrier, and can supply up to 70% of the brain's energy needs after several days of fasting—dramatically reducing the brain's glucose requirement and thereby the need for gluconeogenesis from protein. BHB is now recognized as more than a fuel: it acts as a signaling molecule, inhibiting HDAC enzymes (with epigenetic effects) and activating the NLRP3 inflammasome-inhibiting pathways, contributing to fasting's anti-inflammatory effects.

Autophagy: Cellular Self-Cleaning

One of the most actively researched fasting effects is the induction of autophagy—a cellular recycling process in which damaged proteins, dysfunctional organelles, and intracellular pathogens are engulfed by autophagosomes and degraded. Autophagy is suppressed by insulin and the nutrient-sensing protein complex mTORC1; fasting-induced insulin reduction and nutrient depletion activate autophagy via AMPK activation. Yoshinori Ohsumi received the 2016 Nobel Prize in Physiology or Medicine for his work elucidating autophagy mechanisms. While the therapeutic implications are promising—including potential roles in cancer prevention, neurodegeneration, and longevity—most evidence currently comes from animal models, and the optimal fasting duration to maximize autophagy in humans is not yet defined.

Common Fasting Protocols

Effects on Metabolic Health

A substantial body of research documents fasting's effects on metabolic parameters:

• Insulin sensitivity: Short-term fasting significantly improves insulin sensitivity and reduces fasting insulin levels—particularly beneficial for those with prediabetes or metabolic syndrome.
• Weight and body composition: Most intermittent fasting protocols produce weight loss primarily through reduced total caloric intake; fat mass decreases while lean mass is broadly preserved.
• Lipid profile: Fasting typically reduces triglycerides; effects on LDL and HDL cholesterol vary by protocol and individual.
• Inflammatory markers: Multiple studies report reductions in C-reactive protein (CRP), interleukin-6 (IL-6), and other inflammatory markers during IF.
• Blood pressure: Modest reductions, likely mediated through weight loss and sympathetic nervous system modulation.

Who Should Exercise Caution

Fasting is not appropriate for everyone. Individuals with type 1 diabetes face hypoglycemia and ketoacidosis risks; those on insulin or sulfonylureas require medication adjustment under medical supervision. Pregnant and breastfeeding women should not fast. People with a history of eating disorders should approach fasting cautiously, as it may trigger restrictive behaviors. Extended fasting beyond 24 hours requires medical oversight due to risks including electrolyte imbalances, orthostatic hypotension, and refeeding syndrome if followed by rapid high-carbohydrate consumption.